Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by RONALD P RAPINI and MICHAEL TETZLAFF.
RONALD P RAPINI
Connection Strength
0.265
MICHAEL TETZLAFF
  1. Emerging clinical applications of selected biomarkers in melanoma. Clin Cosmet Investig Dermatol. 2015; 8:35-46.
    View in: PubMed
    Score: 0.126
  2. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. Am J Dermatopathol. 2017 May; 39(5):388-392.
    View in: PubMed
    Score: 0.037
  3. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol. 2017 Feb; 44(2):158-176.
    View in: PubMed
    Score: 0.036
  4. Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions. J Cutan Pathol. 2016 Aug; 43(8):688-96.
    View in: PubMed
    Score: 0.034
  5. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma. Am J Dermatopathol. 2015 Aug; 37(8):e96-9.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.